A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol

Detalles Bibliográficos
Autores principales: Matsuda, M, Hasegawa, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2020
Materias:
ISCP Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312543/
https://www.ncbi.nlm.nih.gov/pubmed/32612707
http://dx.doi.org/10.15420/ecr.2020.15.1.PO24
_version_ 1783549753448988672
author Matsuda, M
Hasegawa, K
author_facet Matsuda, M
Hasegawa, K
author_sort Matsuda, M
collection PubMed
description
format Online
Article
Text
id pubmed-7312543
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-73125432020-06-30 A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol Matsuda, M Hasegawa, K Eur Cardiol ISCP Posters Radcliffe Cardiology 2020-05-15 /pmc/articles/PMC7312543/ /pubmed/32612707 http://dx.doi.org/10.15420/ecr.2020.15.1.PO24 Text en Copyright © 2020, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle ISCP Posters
Matsuda, M
Hasegawa, K
A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
title A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
title_full A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
title_fullStr A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
title_full_unstemmed A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
title_short A Multicentre, Open-Label, Randomised Controlled Clinical Trial to Assess the Efficacy and Safety of Appropriate Target Values for Lipid Management in Patients who Have Mild to Moderate Stenotic Lesions with High-Risk Plaques in Coronary Arteries: Study Protocol
title_sort multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild to moderate stenotic lesions with high-risk plaques in coronary arteries: study protocol
topic ISCP Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312543/
https://www.ncbi.nlm.nih.gov/pubmed/32612707
http://dx.doi.org/10.15420/ecr.2020.15.1.PO24
work_keys_str_mv AT matsudam amulticentreopenlabelrandomisedcontrolledclinicaltrialtoassesstheefficacyandsafetyofappropriatetargetvaluesforlipidmanagementinpatientswhohavemildtomoderatestenoticlesionswithhighriskplaquesincoronaryarteriesstudyprotocol
AT hasegawak amulticentreopenlabelrandomisedcontrolledclinicaltrialtoassesstheefficacyandsafetyofappropriatetargetvaluesforlipidmanagementinpatientswhohavemildtomoderatestenoticlesionswithhighriskplaquesincoronaryarteriesstudyprotocol
AT matsudam multicentreopenlabelrandomisedcontrolledclinicaltrialtoassesstheefficacyandsafetyofappropriatetargetvaluesforlipidmanagementinpatientswhohavemildtomoderatestenoticlesionswithhighriskplaquesincoronaryarteriesstudyprotocol
AT hasegawak multicentreopenlabelrandomisedcontrolledclinicaltrialtoassesstheefficacyandsafetyofappropriatetargetvaluesforlipidmanagementinpatientswhohavemildtomoderatestenoticlesionswithhighriskplaquesincoronaryarteriesstudyprotocol

Ejemplares similares